Synthesis, characterization of dextran hydrogels and their in vitro release of gentamycin sulphate

Journal of Applied Biomaterials & Functional Materials
Rui GuoYuanming Zhang

Abstract

This study reports on the synthesis and characterization of biodegradable dextran-allyl isocyanate-ethylamine (Dex-AE)/polyethylene glycol-diacrylate (PEGDA) hydrogels for the controlled release of gentamycin sulphate (GS) and in vitro inhibition of organisms. The Dex-AE precursor was prepared through a 2-step chemical modification and characterized by Fourier transform infrared spectroscopy (FTIR). Scanning electron microscopy (SEM) results revealed that an increase in Dex-AE content led to an initial decrease in pore size of the Dex-AE/PEGDA hydrogels, but a further increase in Dex-AE content resulted in a slightly increase of pore size. The swelling data indicated that the swelling ratio depended on the precursor feed ratio. GS was incorporated into the hydrogels through 2 different methods, i.e., immersed and crosslinked. The crosslinked GS-Dex-AE/PEGDA hydorgels exhibited stronger antimicrobial activities against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Finally, the viscoelastic properties of crosslinked GS-Dex-AE/PEGDA hydorgels were investigated.

References

Jan 5, 2002·Advanced Drug Delivery Reviews·Allan S Hoffman
Apr 11, 2003·Journal of Ethnopharmacology·A GnanamaniMary Babu
Jun 7, 2005·Journal of Colloid and Interface Science·Marcelo A da Silva, Elizabeth P G Arêas
Mar 18, 2006·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Tetsuro KiyozumiMakoto Kikuchi
Jun 24, 2006·Biomaterials·Stéphane G Lévesque, Molly S Shoichet
Apr 5, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Pui Yan LeeLeaf Huang
Feb 16, 2010·The Journal of Trauma·Nele BrusselaersStan Monstrey
Dec 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Guoming SunSharon Gerecht
Dec 6, 2012·Nanomedicine·Guoming Sun, Jeremy J Mao
Apr 30, 2013·Journal of Biomedical Nanotechnology·Dong Nyoung HeoIl Keun Kwon
Apr 30, 2013·Materials Science & Engineering. C, Materials for Biological Applications·M P RibeiroI J Correia

❮ Previous
Next ❯

Citations

Apr 12, 2018·The International Journal of Artificial Organs·Roberta GentiliniPaola Petrini

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
infrared spectroscopy

Software Mentioned

SPSS
ImageJ

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.